Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Powdered carbon with high adsorption levels. Administrated orally, it adsorbs drugs and toxins, avoiding their absorption from the gastrointestinal tract. It also has uses as an antidiarrheal and antiflatulent and for marking breast lesions in mammography.
Since the last update we have not found published data about its excretion in breast milk.
Its zero intestinal absorption (AEMPS 2020 y 1998, Phebra 2018, Torbet 2005) prevents its passing into plasma and therefore into breast milk.
It use is permitted in infants under one year old. (Pediamecum 2015)
Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs: compatible with Breastfeeding. (WHO 2002)